SYNLOGIC, INC. Stock Option, Exercise Price, Decrease
SYNLOGIC, INC. (SYBX) had Stock Option, Exercise Price, Decrease of $1.85 per share as of 2023-11-09, per its 10-K filed 2025-03-06.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:StockOptionExercisePriceDecrease · last filed 2025-03-06
- 2023-11-09: Stock Option, Exercise Price, Decrease $1.85.
| Period end | Stock Option, Exercise Price, Decrease |
|---|---|
| 2023-11-09 | $1.85 10-K · filed 2025-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |